Abstract In 2011, the World Health Organization's (WHO) mental health Gap Action Programme (mhGAP) released evidence-based epilepsy-care guidelines for use in low and middle income countries (LAMICs). From a geographical, sociocultural, and political perspective, LAMICs represent a heterogenous group with significant differences in the epidemiology, etiology, and perceptions of epilepsy. Successful implementation of the guidelines requires local adaptation for use within individual countries. For effective implementation and sustainability, the sense of ownership and empowerment must be transferred from the global health authorities to the local people. Sociocultural and financial barriers that impede the implementation of the guidelines sh...
International audienceAlthough psychiatric and neurological disorders are among the first contributo...
The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access to treat...
abstract: Worldwide there are over 50 million people suffering from epilepsy, eighty percent (80%) o...
SUMMARY: In many developing countries, people with epilepsy do not receive appropriate treatment for...
Purpose of Review: Efforts to improve epilepsy care outcomes in low- and middle-income countries (LM...
International audienceThe majority of people with epilepsy (PWE) live in low- and middle-income coun...
Objective In order to more appropriately apply and understand the “epilepsy treatment gap” (ETG) con...
Objective: In order to more appropriately apply and understand the “epilepsy treatment gap” (ETG) co...
Epilepsy is a common disorder, particularly in poor areas of the world, and can have a devastating e...
International audienceObjective: To assess the current status of initiatives carried out in developi...
According to World Health Organization (WHO), the prevalence of epilepsy is highest in low- and lowe...
There are three major issues of ethical concern related to epilepsy care in the developing world. Fi...
International audienceIntroduction: Epilepsy affects >50 million people worldwide, with 80% of ...
Introduction: The implementation of technology in the field of epileptology has traditionally focuse...
International audienceObjectives: Epilepsy affects more than 50 million people over the world, inclu...
International audienceAlthough psychiatric and neurological disorders are among the first contributo...
The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access to treat...
abstract: Worldwide there are over 50 million people suffering from epilepsy, eighty percent (80%) o...
SUMMARY: In many developing countries, people with epilepsy do not receive appropriate treatment for...
Purpose of Review: Efforts to improve epilepsy care outcomes in low- and middle-income countries (LM...
International audienceThe majority of people with epilepsy (PWE) live in low- and middle-income coun...
Objective In order to more appropriately apply and understand the “epilepsy treatment gap” (ETG) con...
Objective: In order to more appropriately apply and understand the “epilepsy treatment gap” (ETG) co...
Epilepsy is a common disorder, particularly in poor areas of the world, and can have a devastating e...
International audienceObjective: To assess the current status of initiatives carried out in developi...
According to World Health Organization (WHO), the prevalence of epilepsy is highest in low- and lowe...
There are three major issues of ethical concern related to epilepsy care in the developing world. Fi...
International audienceIntroduction: Epilepsy affects >50 million people worldwide, with 80% of ...
Introduction: The implementation of technology in the field of epileptology has traditionally focuse...
International audienceObjectives: Epilepsy affects more than 50 million people over the world, inclu...
International audienceAlthough psychiatric and neurological disorders are among the first contributo...
The worldwide prevalence of epilepsy is variable, estimated at 10//1,000 people, and access to treat...
abstract: Worldwide there are over 50 million people suffering from epilepsy, eighty percent (80%) o...